EP3313818
METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
24.6.2016EP published:
8.11.2023EP application number:
16815375.7
EPO information:
European Patent Register
Max expiry date:
23.6.2036
Title in English:
METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERSLanguage of the patent:
English
Timeline
Today
24.6.2016EP application
8.11.2023EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
Inventor
Name:
YARCHOAN, RobertAddress:
Bethesda, MD 20817, US
Name:
ZELDIS, JeromeAddress:
Princeton, NJ 08540, US
Name:
POLIZZOTTO, MarkAddress:
Paddington, New South Wales 2021, AU
Name:
DAVIS, DavidAddress:
Bethesda, MD 20817, US
Name:
SERETI, IriniAddress:
Washington, DC 20004, US
Name:
ULDRICK, ThomasAddress:
Washington, DC 20005, US
Name:
WHITBY, DeniseAddress:
Frederick, MD 21701, US
Name:
KHETANI, VikramAddress:
Short Hills, NJ 07078, US
Priority
Number:
201562185265 PDate:
26.6.2015Country:
US
Classification
Categories:
C07D 209/48, A61K 31/404, A61K 45/06, C07D 471/04, C07D 473/34, A61P 35/00